Endocrinology

Top Story

Later-onset menarche, menopause associated with longevity

Later-onset menarche, menopause associated with longevity
July 28, 2016

Women with later-onset menarche, later natural or surgical menopause and a longer reproductive lifespan are more likely to live to age 90 years vs. women with early-onset menarche, early menopause or a shorter reproductive lifespan, according to findings published in Menopause.

“Our findings suggest that women who began menstruating at age 12 or older, women experiencing menopause at age 50 or older, and women with more than 40 reproductive years (defined as the difference between age at first menstruation and age at menopause) were more likely to live to age 90,” Aladdin H. Shadyab, PhD, MS, MPH, CPH, postdoctoral fellow in rheumatology and aging at University of California, San Diego School of Medicine, told Endocrine Today. “Future studies are needed to examine how lifestyle, genetics and environmental factors explain the link between reproductive lifespan and longevity.”

FDA News

FDA approves Adlyxin for type 2 diabetes

July 28, 2016
The FDA has approved the once-daily glucagon-like peptide-1 receptor agonist Adlyxin, a once-daily injection to improve glycemic control along with diet and exercise in…
In the Journals

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016
Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic
Health Care Legislative and Regulatory Update

Are the holiday baskets really worth the risk?

July 27, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals Plus

Health-related quality of life lower in parents of children with metabolic disease

July 27, 2016
Parents of children with congenital disorders of metabolism tend to have a lower health-related quality of life vs. parents of children without metabolic disease, with…
More News Headlines »
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video
Meeting News Coverage

VIDEO: Results of LEADER trial provide “robust demonstration” of cardiovascular event reduction in high-risk type 2 diabetes

July 1, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes…
More »
Current Issues
View the Current Issues
morganatic-roan